Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-04
1998-07-14
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514279, A61K 31445
Patent
active
057804796
ABSTRACT:
A method is provided for treating an individual afflicted with an impulse-control disorder by administering thereto an amount of one or more opioid receptor antagonists.
REFERENCES:
patent: 4816586 (1989-03-01), Portoghese
patent: 5086058 (1992-02-01), Sinclair et al.
patent: 5298622 (1994-03-01), Portoghese et al.
patent: 5411965 (1995-05-01), Reid et al.
patent: 5457208 (1995-10-01), Portoghese et al.
"Impulse-Control Disorders Not Elsewhere Classified", Diagnostic and Statistical Manual of Mental Disorders, Fourth Edithion, American Psychiatric Association, Washington, D.C., 609-621 (1994).
Campbell, M., et al., "Naltrexone in Autistic Children: Behavioral Symptoms and Attentional Learning", J. Am. Acad. of Child Adolesc. Psychiatry, 32, 1283-1291 (Nov. 1993).
Carrion, V.G., "Naltrexone for the treatment of Trichotillomania: A Case Report", J. Clin. Psychopharmacol., 15, 444-445 (Dec. 1995).
Cotton, R., et al., "ICI 174864: A Highly Selective Antagonist for the Opioid Delta-Receptor", Eur. J. Pharmacol., 97, 331-332 (1984).
Froehlich, J.C., et al., "Importance of Delta Opioid Receptors in Maintaining High Alcohol Drinking", Psychopharmacology, 103, 467-472 (1991).
Froehlich, J.C., et al., "Naloxone Attenuates Voluntary Ethanol Intake in Rats Selectively Bred for Ethanol Preference", Pharmacology Biochemistry and Behavior, 35, 385-390 (1990).
Hollander, E., et al., "Obsessive Compulsive and Spectrum Disorders: Overview and Quality of Life Issues", J. Clin. Psychiatry, 57, S8, 3-6 (1996).
Insel, T.R., et al., "Naloxone Administration in Obsessive-Compulsive Disorder: Report of Two Cases", Am. J. Psychiatry, 140, 1219-1220 (Sep. 1983).
Jaffe, J.H., et al., "Opioid Analgesics and Antagonists", The Pharmacological Basis of Therapeutics, Gilman, A.G., et al., (eds.), Pergamon Press, New York, 485-521 (1990).
Jonas, J.M., et al., "The Use of Opiate Antagonists in Treating Bulimia: A Study of Low-Dose Versus High-Dose Naltrexone", Psychiatry Research, 24, 195-199 (1988).
Keuler, D.J., et al., "Behavioral Effects of Naloxone Infusion in Obsessive-Compulsive Disorder", Biol. Psychiatry, 40, 154-156 (1996).
Koob, G.F., et al., "Cellular and Molecular Mechanisms of Drug Dependence", Science, 242, 715-723 (4 Nov. 1988).
Kosten, T.R., et al., "Role of Opioid Antagonists in Treating Intravenous Cocaine Abuse", Life Sciences, 44, 887-892 (1989).
Martin, W.R., "Pharmacology of Opioids", Pharmacological Reviews, 35, 283-323 (1984).
McElroy, S.L., et al., "Clinical and Theoretical Implications of a Possible Link Between Obsessive-Compulsive and Impulse Control Disorders", Depression, 1, 121-132, (1993).
Roth, A.S., et al., "Naltrexone as a Treatment for Repetitive Self-Injurious Behavior: An Open-Label Trial", J. Clin. Psychiatry, 57, 233-237 (1996).
Sandyk, R., "Naloxone Abolishes Obsessive-Compulsive Behavior in Tourette's Syndrome", Intern. J. Neuroscience, 35, 93-94 (1987).
Shaw, J.S., et al., "Selective Antagonists at the Opiate Delta-Receptor", Life Sciences, 31, 1259-1262 (1982).
Sofuoglu, M., et al., "Differential Antagonism of Delta Opioid Agonists by Naltrindole and Its Benzofuran Analog (NTB) in Mice: Evidence for Delta Opioid Receptor Subtypes", J. Pharmacol. and Exper. Therapeutics, 257, 676-680 (1991).
Stein, D.J., et al., "Trichotillomania and Obsessive-Compulsive Disorder", J. Clin. Psychiatry, 56, S4, 28-35 (1995).
Swedo, S.E., et al., "Trichotillomania: An Obsessive-Compulsive Spectrum Disorder?", Obsessional Disorders, 15, 777-790 (Dec. 1992).
Volpicelli, J.R., et al., "Effect of Naltrexone on Alcohol High in Alcholics", Am. J. Psychiatry, 152, 613-615, (1995).
Volpicelli, J.R., et al., "Naltrexone in the Treatment of Alcohol Dependence", Arch. Gen. Psychiatry, 49, 876-880, (Nov. 1992).
Volpicelli, J.R., et al., "Naltrexone in the Treatment of Alcoholism: Predicting Response to Naltrexone", J. Clin. Psychiatry, S7, 39-44 (1995).
Willemsen-Swinkels, S.H., et al., "Failure of Naltrexone Hydrochloride to Reduce Self-Injurious and Autistic Behavior in Mentally Retarded Adults. Double-Blind Placebo-Controlled Studies", Arch. Gen. Psychiatry, 52, 766-773 (Sep. 1995).
Christenson et al., CNS Drugs, 6(1), 24-34 (1996).
Regents of the University of Minnesota
Spivack Phyllis G.
LandOfFree
Use of opioid antagonists to treat impulse-control disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of opioid antagonists to treat impulse-control disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of opioid antagonists to treat impulse-control disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1882078